昌吉几个月可以打胎(昌吉哪家医院治尿道炎) (今日更新中)

When Brooke Harrison picked up her backpack Sunday during orientation day at Marjory Stoneman Douglas High School, there were two things different about it. A blue name tag made out of tape and a bullet hole near the bottom. FULL COVERAGE: Parkland school shooting“(The bullet) could have gone through my backpack, but I’m pretty sure it just grazed it or slightly passed it. The fact that my backpack was so close to me is really mind blowing,” Brooke said.It was left in her freshman classroom where five classmates were shot. Three of them died: Alyssa Alhadeff, Alex Schachter and Alaina Petty. Seventeen people died in total. “We know how lucky we are,” said Brooke’s mom, Denise Harrison. “From the stories we already heard in the classroom, we go pick up the backpack we saw this. Everyday, we’re saying to ourselves, we’re so lucky.”On Wednesday, Brooke and the student body return to campus.“It’s going to be sad because I’m going to remember the fact that three of my classmates won’t be able to go back to school and that three of them won’t be able to see their friends and see that everyone is okay,” Brooke said. Her parents aren’t worried about Wednesday or the next day. They know security will be tight when they return, but beyond that there's uncertainty.“One of the greater concerns that we have is, what happens next?” said Robert Harrison, Brooke’s dad. “When the news cycle ended and six months have gone by, what actions will have been taken to ensure this doesn’t ever happen again? At this school or any other.” For starters, they want more armed school resource officers and a review of code red protocol. “To give ourselves as parents, to give us the ability to know when you drop your kid off, they’re going to be safe,” Harrison said. On top of the friends they lost, they lost their innocence. Every hug and every “I love you” means more now. “Time just feels more precious now. It feels like we have to reaffirm that. I know they love me, and I know I love them, but it feels like we need to say it more now,” Brooke said. Brooke’s parents have been through tragedy before. They lived just two blocks away from the World Trade Center during the 9/11 attack. 2277

With coronavirus cases ramping up in a number of US states, more and more US governors have issued mandates to wear masks while in public settings.The continued spike in COVID-19 cases has caused several states to close bars and pause plans to reopen some businesses such as movie theaters.While a number of states had previously mandated masks in many public spaces, several more have been added to the list in recent days. Requiring face coverings are largely being seen as a way to avoid reinstituting stay-at-home orders, which most states implemented during the spring.Researchers from the University of Washington say that a projected 33,000 American lives would be saved between June 23 and October 1 if 95% of the population wore masks in public settings.A study in the Lancet found that the use of masks and respirators by those infected with the virus reduced the risk of spreading the infection by 85%. The authors analyzed data that showed that N95 respirators in healthcare settings were up to 96% effective. Other masks were found to be 77% effective.The following states generally require face coverings to be worn in public:Alabama - July 16Arkansas - July 16California – June 18Colorado - July 17Connecticut – April 20Delaware – May 1District of Columbia – May 16Hawaii - April 17Illinois – April 30Indiana - July 27Kansas - July 3Kentucky - July 10Louisiana - July 13Maine – April 29Maryland – April 18Massachusetts – May 6Michigan - April 24Minnesota - July 25Montana - July 16Nevada – June 24New Jersey - April 10New Mexico – May 15New York – April 15North Carolina – June 26Ohio - July 23Oregon - July 1Pennsylvania – April 18Puerto Rico Rhode Island – May 8Texas - July 2Vermont - August 1Virginia - June 8Washington - June 26West Virginia - July 7Some states, like Ohio and Texas, require mask wearing only in counties where there are high coronavirus case rates. More than a dozen other states have issued recommendations for wearing masks. Some of those states require employees in certain fields to wear a mask while at work. 2059

WINTER PARK, Fla. (AP) — Police say a man punched and kicked a 70-year-old man who'd asked him to practice social distancing inside a central Florida gas station. An arrest report says 24-year-old Rovester Ingram wasn't wearing a mask so the older man asked him to back away on Sept. 8. The man then paid for his items and left the store. Police say Ingram followed him outside and began punching and kicking him. The man went back inside. But Ingram followed him and dragged him back out. Police confirmed the incident through witnesses and surveillance video. They arrested Ingram. 591

When you go out to eat or visit the grocery store, you’ll probably spot an employee wiping down tables or spraying carts with disinfectant. These sanitizers can kill the novel coronavirus, but doctors warn some can also cause chemical burns and allergic reactions on your skin.“Depending on the strength of these disinfectants, they can cause damage to the skin. They can react like a burn would, which can appear with significant redness or swelling to the skin,” said Dr. Frederick Davis, who works in the emergency department at the Long Island Jewish Medical Center.One Florida family believes their baby got a chemical burn after sitting in a Walmart cart sprayed with disinfectant.Davis said alcohol, bleach and ammonia, often used in commercial sanitizers, can create that reaction.“A lot of these cases, unfortunately, happen because people think it’s a disinfectant, it kills bacteria and viruses, it’s safe to apply to the skin, but it definitely isn’t,” he said.Environmental Biology Professor at the University of Arizona Dr. Charles Gerba said commercial disinfectant can be harmful to skin until it dries completely.“You don’t want to put the child down in the seat if it’s wet with disinfectant,” warned Gerba.Parents should dry carts or any surface covered in disinfectant before letting kids touch them, but experts caution, disinfectants may not work properly if they cannot dry on their own.So, to keep your kids safe and kill the germs, Dr. Gerba recommends placing a towel down in the cart or using a baby wipe to remove harsh chemicals that can build up over time.“That’s one of my concerns,” said Gerba. “You keep adding these chemical disinfectants on every single day, they’re subject to misuse, like not drying enough, so you might get some exposure,” he said.Because of these dangers, Dr. Gerba is experimenting with a replacement for commercial grade sanitizers with a company called Allied Bioscience. It’s a spray coating that sticks to any surface, even touch screens, and kills bacteria and viruses for months at a time.“It’s the same principle as odor eater socks,” said Gerba. “The reason the socks didn’t smell is it killed the bacteria that caused the odors,” he explained.Michael Ruley is the CEO of Allied Bioscience and said he hopes this coating will make its way onto airplanes, into schools and grocery stores soon. “With this coating going down, it gets ahead of the threat and is proactive instead of reactive,” Ruley said.This new technology is still getting approved by the EPA, but studies show it can fight the coronavirus.“They killed the coronavirus pretty well, like 99 percent or more, within a few minutes sometimes,” Gerba said.This product needs to be applied once every 90 days to remain effective, which would lift much of the workload off employees to clean places.“That’s the whole goal is to get people back feeling comfortable in the environment and be able to go out and enjoy their environment,” said Ruley.But until the frequent sanitizing ends, Dr. Gerba warns just because a surface is clean, doesn’t mean it’s safe for you or your kids to touch. He said the best way to protect your skin is to immediately wash your hands after touching anything that’s been sanitized. 3243

With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them.Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines work by tricking the body into thinking there’s an infection so it makes antibodies and remembers how to do that if the real bug turns up.But it can take a month or two after vaccination or infection for the most effective antibodies to form. The experimental drugs shortcut that process by giving concentrated versions of specific ones that worked best against the coronavirus in lab and animal tests.“A vaccine takes time to work, to force the development of antibodies. But when you give an antibody, you get immediate protection,” said University of North Carolina virologist Dr. Myron Cohen. “If we can generate them in large concentrations, in big vats in an antibody factory ... we can kind of bypass the immune system.”These drugs are believed to last for a month or more and could give quick, temporary immunity to people at high risk of infection, such as health workers and housemates of someone with COVID-19. If they proved effective and if a vaccine doesn’t materialize or protect as hoped, the drugs might eventually be considered for wider use, perhaps for teachers or other groups.They’re also being tested as treatments, to help the immune system and prevent severe symptoms or death.“The hope there is to target people who are in the first week of their illness and that we can treat them with the antibody and prevent them from getting sick,” said Dr. Marshall Lyon, an infectious disease specialist helping to test one such drug at Emory University in Atlanta.Having such a tool “would be a really momentous thing in our fight against COVID,” Cohen said.Vaccines are seen as a key to controlling the virus, which has been confirmed to have infected more than 20 million people worldwide and killed more than 738,000. Several companies are racing to develop vaccines, but the results of the large final tests needed to evaluate them are months away.The antibody drugs are “very promising” and, in contrast, could be available “fairly soon,” said Dr. Janet Woodcock, a U.S. Food and Drug Administration official who is leading government efforts to speed COVID-19 therapies. Key studies are underway and some answers should come by early fall.One company, Eli Lilly, has already started manufacturing its antibody drug, betting that studies now underway will give positive results.“Our goal is to get something out as soon as possible” and to have hundreds of thousands of doses ready by fall, said Lilly’s chief scientific officer, Dr. Daniel Skovronsky.Another company that developed an antibody drug cocktail against Ebola — Regeneron Pharmaceuticals Inc. — now is testing one for coronavirus.“The success with our Ebola program gives us some confidence that we can potentially do this again,” said Christos Kyratsous, a Regeneron microbiologist who helped lead that work.Regeneron’s drug uses two antibodies to enhance chances the drug will work even if the virus evolves to evade action by one.Lilly is testing two different, single-antibody drugs — one with the Canadian company AbCellera and another with a Chinese company, Junshi Biosciences. In July, Junshi said no safety concerns emerged in 40 healthy people who tried it and that larger studies were getting underway.Others working on antibody drugs include Amgen and Adaptive Biotechnologies. The Singapore biotech company Tychan Pte Ltd. also is testing an antibody drug and has similar products in development for Zika virus and yellow fever.“I’m cautiously optimistic” about the drugs, said the nation’s top infectious diseases expert, Dr. Anthony Fauci. “I’m heartened by the experience that we had with Ebola,” where the drugs proved effective.What could go wrong?— The antibodies may not reach all of the places in the body where they need to act, such as deep in the lungs. All the antibody drugs are given through an IV and must make their way through the bloodstream to wherever they’re needed.— The virus might mutate to avoid the antibody — the reason Regeneron is testing a two-antibody combo that binds to the virus in different places to help prevent its escape.Skovronsky said Lilly stuck with one antibody because manufacturing capacity would essentially be cut in half to make two, and “you will have less doses available.” If a single antibody works, “we can treat twice as many people,” he said.— The antibodies might not last long enough. If they fade within a month, it’s still OK for treatment since COVID-19 illness usually resolves in that time. But for prevention, it may not be practical to give infusions more often than every month or two.A San Francisco company, Vir Biotechnology Inc., says it has engineered antibodies to last longer than they usually do to avoid this problem. GlaxoSmithKline has invested 0 million in Vir to test them.Giving a higher dose also may help. If half of antibodies disappear after a month, “if you give twice as much, you will have two months’ protection,” Lilly’s Skovronsky said.— The big fear: Antibodies may do the opposite of what’s hoped and actually enhance the virus’s ability to get into cells or stimulate the immune system in a way that makes people sicker. It’s a theoretical concern that hasn’t been seen in testing so far, but large, definitive experiments are needed to prove safety.“As best as we can tell, the antibodies are helpful,” Lyon said.___Marilynn Marchione can be followed on Twitter: @MMarchioneAP___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5919

来源：资阳报